BioCentury
ARTICLE | Finance

Warp Drive’s winding road to Revolution

Behind Warp Drive’s journey to Revolution

October 19, 2018 6:41 PM UTC

After winding through nearly seven years of shifting strategies and a delayed entry into the clinic, Warp Drive Bio Inc. has opted for a takeout by fellow Third Rock Ventures portfolio company Revolution Medicines Inc. in search of a path to the clinic and public market capital.

Financial terms of the deal are undisclosed beyond noting that Warp Drive investors will receive Revolution stock. The deal is slated to close this month. ...